The Globe and Mail Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
Frank Gunn/The Canadian Press
Health Canada has approved a label change to Pfizer-BioNTech’s COVID-19 vaccine that will see an extra dose withdrawn from each vial, giving the Liberal government’s beleaguered vaccination campaign a boost but putting more pressure on the people administering the shots.
Officials with the federal regulator said Tuesday that six doses, rather than five, can be “obtained reliably and consistently” from each vial of the vaccine. That rebuts the position from some provincial officials, who have said the sixth dose should be treated as a bonus because the extra shot cannot be reliably extracted.
With new and more contagious variants of COVID-19 escalating in Canada, provincial governments lifting lockdown restrictions must be ready to slam them back into place at a moment's notice, Canada's chief public health doctor said on Tuesday, February 9, 2021.
Federal Update on COVID-19 Vaccine Distribution – December 23, 2020
On Parliament Hill, Dr. Howard Njoo, Canada’s deputy chief public health officer, conducts a technical briefing concerning Canada’s distribution of COVID-19 vaccines. He also discusses Health Canada’s approval of Moderna’s COVID-19 vaccine. This is the second COVID-19 vaccine to be approved for use in Canada. The Pfizer-BioNTech vaccine was approved on December 9 and the first vaccinations in the country began on December 14. Dr. Njoo is joined by Major-General Dany Fortin (vice-president of logistics and operations at the Public Health Agency of Canada and head of the country’s vaccine distribution efforts); Dr. Supriya Sharma (a senior medical advisor with Health Canada); Dr. Marc Berthiaume (the director of the Bureau of Medical Science at Health Canada); Dr. Tom Wong (the executive director and chief medical officer of public health at Indigenous Services Canada); and Arianne Reza (assistant deputy m
Health Canada Officials Discuss Approval of Moderna COVID-19 Vaccine
Federal health officials hold a news conference on Parliament Hill to provide an update on Health Canada’s approval of Moderna’s COVID-19 vaccine. Speaking with reporters are Dr. Supriya Sharma, a senior medical advisor with Health Canada, and Dr. Marc Berthiaume, the director of the Bureau of Medical Science at Health Canada. This is the second COVID-19 vaccine to be approved for use in Canada. The Pfizer-BioNTech vaccine was approved on December 9 and the first vaccinations in the country began on December 14. Up to 168,000 doses of the Moderna vaccine are expected to arrive in Canada by the end of 2020. Unlike the Pfizer vaccine, Moderna’s does not need to be stored in specialized freezers at extremely cold temperatures. Health Canada’s approval of the Moderna vaccine means that COVID-19 vaccinations can begin in Canada’s northern regions, as well as remote and Indigenous communities. (December 23, 202
Can I get the COVID-19 vaccine if I have allergies? macleans.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from macleans.ca Daily Mail and Mail on Sunday newspapers.